Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Amicus closes its largest financing round; brings in $60mm
19 Sep 2006
After withdrawing its IPO last month, Amicus Therapeutics (develops small molecules for genetic diseases) raised $60mm in its Series D round led by returning shareholder New Enterprise Associates. New backer Och-Ziff Capital Management was joined by existing investors Canaan Partners, CHL Medical Partners, Frazier Healthcare Ventures, Palo Alto Investors, Prospect Venture Partners, Quaker BioVentures, and Radius Ventures.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?